Multi-Institutional, Prospective Clinical Utility Study Evaluating the Impact of the 92-Gene Assay (CancerTYPE ID) on Final Diagnosis and Treatment Planning in Patients With Metastatic Cancer With an Unknown or Unclear Diagnosis
Thomas, Sachdev P., Jacobson, Lauren E., Victorio, Anthony R., Operaña, Theresa N., Schroeder, Brock E., Schnabel, Catherine A., Braiteh, FadiLanguage:
english
Journal:
JCO Precision Oncology
DOI:
10.1200/PO.17.00145
Date:
March, 2018
File:
PDF, 711 KB
english, 2018